Vimarsana
Biggest News Aggregation in the World

Page 12 - Systemic Lupus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Systemic Lupus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Systemic Lupus Today - Breaking & Trending Today

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 - Vimarsana News

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Systemic Lupus Erythematosus Market to Advance Upto Whopping USD 10 Billion by 2030 - Vimarsana News

Systemic Lupus Erythematosus Market to Advance Upto Whopping USD 10 Billion by 2030

/PRNewswire/ -- DelveInsight's Systemic Lupus Erythematosus Market Insights report proffers a detailed comprehension of the Systemic Lupus Erythematosus market...

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR21 - Vimarsana News

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR21

DGAP-News: MorphoSys AG / Key word(s): AgreementMorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 14.06.2022 / 22:01 The issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, South San Francisco, United States, June...

DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 - Vimarsana News

DGAP-News: MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

DGAP-News: MorphoSys AG / Key word(s): Agreement MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felza...

Arthritis National Research Foundation Announces 2022-23 Grant Recipients - Vimarsana News

Arthritis National Research Foundation Announces 2022-23 Grant Recipients

Early-career scientists receive funding to pursue arthritis and related autoimmune disease researchIRVINE, Calif.--(BUSINESS WIRE)--The Arthritis National Research Foundation (ANRF) today announced the 19 early-career scientists who will receive grant funding and make up the 2022-23 cohort. The eight first-year gran...